Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439802 · ClinicalTrials.gov registry record · Phase 4
Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
A Phase 4 study of Intrauterine Device Expulsion, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT01439802: Completed Phase 4 study of Intrauterine Device Expulsion, sponsored by Albert Einstein College of Medicine.
NCT01439802 is a Phase 4 study of Intrauterine Device Expulsion that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 90 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01439802, a Phase 4 study of Intrauterine Device Expulsion, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
Primary Outcome
Number of participants with Expulsion of IUDs placed at time of cesarean delivery.
Conditions Studied
Interventions
- DEVICE Copper IUD placement at time Cesarean Delivery (Copper T 380A)
Study Locations (2)
New York
- Jacobi Medical Center - The Bronx
- Montefiore Medical Center, Weiler Division - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
What the finished NCT01439802 record still lists
NCT01439802 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Intrauterine Device Expulsion appearing as the primary indexed condition, and to 1 intervention - of which Copper IUD placement at time Cesarean Delivery (Copper T 380A) is the first listed.
NCT01439802 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01439802 about?
NCT01439802 is a clinical study titled "Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery". The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
What is the current status of trial NCT01439802?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2008-08. Estimated completion is 2010-05.
What conditions does trial NCT01439802 study?
This clinical trial studies the following conditions: Intrauterine Device Expulsion.
What interventions are being tested in trial NCT01439802?
The interventions under investigation include: Copper IUD placement at time Cesarean Delivery (Copper T 380A) (DEVICE).
Who is sponsoring clinical trial NCT01439802?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01439802 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01439802's enrollment target sits among peer trials
90 886th of 2000 higher than 1,089 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia